Reckitt To Pay $1.4B To End US Opioid Probe

Law360, London (July 11, 2019, 12:38 PM BST) -- British pharmaceutical company Reckitt Benckiser said Thursday it will pay U.S. authorities up to $1.4 billion to settle a long-running investigation into sales of a treatment for addiction to opioids by its former prescription drugs business.

The settlement of up to $1.4 billion with the U.S. Department of Justice and the Federal Trade Commission ends an inquiry into the sales and marketing of an opioid-based drug. (AP) The settlement with the U.S. Department of Justice and the Federal Trade Commission ends an inquiry into the sales and marketing of Suboxone Film, an opioid-based drug. Authorities in the U.S. allege that Indivior...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS